BeiGene Initiates Global Phase 3 Trial of Anti-PD-1 Antibody Tislelizumab in Patients with Esophageal Squamous Cell Carcinoma Pharmaceutical Investing
Vical Announces Restructuring to Focus Resources on HSV-2 and Antifungal Clinical Programs Pharmaceutical Investing
Novelion Therapeutics Announces Sentencing of Subsidiary Aegerion Pharmaceuticals Pharmaceutical Investing
Published Study Demonstrates the Association Between Immunovaccine’s Proprietary Immune-targeted Delivery Technology Biotech Investing
Protalix BioTherapeutics’ pegunigalsidase alfa Receives Fast Track Designation from the U.S. Food and Drug Administration Pharmaceutical Investing
Bellicum Pharmaceuticals Announces Clinical Hold on BPX-501 Clinical Trials in the United States Pharmaceutical Investing
Sirona Biochem Announces Development of Anti-Wrinkle Treatment and Update from J.P. Morgan Healthcare Conference Pharmaceutical Investing
Aequus and Camargo Prepare for Meeting with FDA to Advance Anti-Nausea Patch Pharmaceutical Investing
Corbus Pharmaceuticals Announces Agreement with FDA on Phase 2b Cystic Fibrosis Study Design Pharmaceutical Investing
Elite Pharmaceuticals Reports Positive Topline Results from SequestOx™ Pilot Study Pharmaceutical Investing
InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
